SonoScape Medical Corp (300633) - Total Liabilities
Based on the latest financial reports, SonoScape Medical Corp (300633) has total liabilities worth CN¥1.04 Billion CNY (≈ $151.55 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are SonoScape Medical Corp's assets to evaluate the company's liquid asset resilience ratio.
SonoScape Medical Corp - Total Liabilities Trend (2012–2025)
This chart illustrates how SonoScape Medical Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 300633 total asset value.
SonoScape Medical Corp Competitors by Total Liabilities
The table below lists competitors of SonoScape Medical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vossloh AG
F:VOS
|
Germany | €1.38 Billion |
|
Collective Mining Ltd
TO:CNL
|
Canada | CA$12.92 Million |
|
United Corporations Limited
TO:UNC
|
Canada | CA$154.84 Million |
|
Chemtrade Logistics Income Fund
TO:CHE-UN
|
Canada | CA$1.54 Billion |
|
Jiangsu Favored Nanotechnology Co. Ltd. A
SHG:688371
|
China | CN¥140.31 Million |
|
Temple Bar Investment Trust
LSE:TMPL
|
UK | £76.82 Million |
|
Ingles Markets Incorporated
NASDAQ:IMKTA
|
USA | $948.71 Million |
|
Suzhou Kingswood Printing Ink Co Ltd
SHE:300192
|
China | CN¥255.93 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down SonoScape Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is SonoScape Medical Corp's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SonoScape Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SonoScape Medical Corp (2012–2025)
The table below shows the annual total liabilities of SonoScape Medical Corp from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.14 Billion ≈ $167.38 Million |
-5.06% |
| 2024-12-31 | CN¥1.20 Billion ≈ $176.30 Million |
+92.62% |
| 2023-12-31 | CN¥625.46 Million ≈ $91.52 Million |
-22.25% |
| 2022-12-31 | CN¥804.41 Million ≈ $117.71 Million |
+20.93% |
| 2021-12-31 | CN¥665.18 Million ≈ $97.34 Million |
-26.66% |
| 2020-12-31 | CN¥906.93 Million ≈ $132.71 Million |
-10.22% |
| 2019-12-31 | CN¥1.01 Billion ≈ $147.81 Million |
+92.52% |
| 2018-12-31 | CN¥524.67 Million ≈ $76.78 Million |
+90.15% |
| 2017-12-31 | CN¥275.93 Million ≈ $40.38 Million |
-6.92% |
| 2016-12-31 | CN¥296.44 Million ≈ $43.38 Million |
-19.78% |
| 2015-12-31 | CN¥369.52 Million ≈ $54.07 Million |
-10.63% |
| 2014-12-31 | CN¥413.48 Million ≈ $60.51 Million |
+58.62% |
| 2013-12-31 | CN¥260.67 Million ≈ $38.14 Million |
-3.31% |
| 2012-12-31 | CN¥269.59 Million ≈ $39.45 Million |
-- |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more